- Home
- ME vs CLDI Comparison
ME vs CLDI Comparison
Compare ME & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ME
- CLDI
- Stock Information
- Founded
- ME 2006
- CLDI 2014
- Country
- ME United States
- CLDI United States
- Employees
- ME N/A
- CLDI N/A
- Industry
- ME Precision Instruments
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ME Health Care
- CLDI Health Care
- Exchange
- ME Nasdaq
- CLDI Nasdaq
- Market Cap
- ME 40.0M
- CLDI 35.2M
- IPO Year
- ME N/A
- CLDI N/A
- Fundamental
- Price
- ME $1.82
- CLDI $0.78
- Analyst Decision
- ME Hold
- CLDI Strong Buy
- Analyst Count
- ME 1
- CLDI 3
- Target Price
- ME $9.40
- CLDI $16.67
- AVG Volume (30 Days)
- ME 466.4K
- CLDI 790.1K
- Earning Date
- ME 01-28-2025
- CLDI 03-18-2025
- Dividend Yield
- ME N/A
- CLDI N/A
- EPS Growth
- ME N/A
- CLDI N/A
- EPS
- ME N/A
- CLDI N/A
- Revenue
- ME $208,775,000.00
- CLDI N/A
- Revenue This Year
- ME $22.00
- CLDI N/A
- Revenue Next Year
- ME $17.31
- CLDI N/A
- P/E Ratio
- ME N/A
- CLDI N/A
- Revenue Growth
- ME N/A
- CLDI N/A
- 52 Week Low
- ME $1.34
- CLDI $0.58
- 52 Week High
- ME $12.76
- CLDI $8.30
- Technical
- Relative Strength Index (RSI)
- ME 37.81
- CLDI 40.01
- Support Level
- ME $1.48
- CLDI $0.73
- Resistance Level
- ME $1.75
- CLDI $0.95
- Average True Range (ATR)
- ME 0.17
- CLDI 0.12
- MACD
- ME 0.02
- CLDI -0.01
- Stochastic Oscillator
- ME 40.43
- CLDI 19.02
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.